Seeking Alpha

BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test

Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and ...
FierceBiotech

BD collects full FDA clearance for 'tripledemic' infection test

After receiving one of a dwindling number of COVID-era FDA emergency authorizations earlier this year, BD has converted its combination respiratory virus test to a full regulatory green light. The ...
Seeking Alpha

BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test

New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global ...
Morningstar

BD Continues Growing Even as COVID-19 Testing Pulls Back

We are maintaining our $306 fair value estimate for narrow-moat Becton, Dickinson as we update our model following fiscal third-quarter results and updated full-year guidance. BD increased its revenue ...
FierceBiotech

Despite COVID testing crash and stagnant base business, BD brightens 2023 outlook

Amid the standard roll call of earnings sheets released in recent weeks, nearly every diagnostics developer marked present has reported a severe drop-off in COVID-19 test sales for the fourth quarter ...
Nasdaq

BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test

FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
Nasdaq

BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test

FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...